Home › Funds › UBS Group AG › APYX
UBS Group AG position in APYX
APYX MEDICAL CORPORATION · Health Care
Latest position (Q2 2026)12.75K sh
Reported value held$57.25K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 3.00K | $42.00K | New |
| Q4 2021 | 3.00K | $38.00K | Hold |
| Q2 2022 | 881.61K | $5.17M | New |
| Q3 2022 | 889.04K | $3.99M | Add |
| Q4 2022 | 617 | $1.44K | Reduce |
| Q1 2023 | 582 | $1.68K | Reduce |
| Q2 2023 | 400 | $2.01K | Reduce |
| Q3 2023 | 400 | $1.28K | Hold |
| Q4 2023 | 4.28K | $11.21K | Add |
| Q1 2024 | 504 | $685 | Reduce |
| Q2 2024 | 1.27K | $1.71K | Add |
| Q3 2024 | 705 | $874 | Reduce |
| Q4 2024 | 3.85K | $6.08K | Add |
| Q1 2025 | 4.31K | $5.90K | Add |
| Q2 2025 | 405 | $911 | Reduce |
| Q3 2025 | 12.72K | $27.21K | Add |
| Q4 2025 | 1.43K | $5.00K | Reduce |
| Q1 2026 | 231.34K | $853.66K | Add |
| Q2 2026 | 12.75K | $57.25K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding APYX
- Royce & Associates 3.27M sh · $14.70M · Q2 2026
- Vanguard Group 1.57M sh · $5.48M · Q4 2025
- BlackRock Inc 560.99K sh · $2.52M · Q2 2026
- Renaissance Technologies 554.28K sh · $2.49M · Q2 2026
- Geode Capital Management 400.60K sh · $1.80M · Q2 2026
- Millennium Management 242.66K sh · $1.09M · Q2 2026
- Marshall Wace 236.47K sh · $1.06M · Q2 2026
- Citadel Advisors 168.34K sh · $755.86K · Q2 2026
- Northern Trust Corp 78.57K sh · $352.77K · Q2 2026
- Goldman Sachs Group 44.39K sh · $199.30K · Q2 2026
- Morgan Stanley 41.34K sh · $185.60K · Q2 2026
- Point72 Asset Management 26.35K sh · $118.31K · Q2 2026